Used in the synthesis of pharmaceutical intermediates, particularly in the development of selective estrogen receptor modulators (SERMs). It serves as a key building block in creating compounds with tissue-specific estrogenic activity, useful in treating conditions like osteoporosis and hormone-responsive cancers. Its structural configuration allows for enhanced binding affinity and metabolic stability in target molecules. Commonly employed in research settings for optimizing drug candidates with improved pharmacokinetic profiles.